Description
A prodrug form of chloramphenicol; a substrate for SDH; is oxidized by human liver and rat liver and kidney mitochondria to release chloramphenicol in vitro; reduces human leukocyte migration in vitro; reduces E. coli growth in rabbit and rat models of pyelonephritis at 150 and 200 mg/kg, respectively; reduces infarct size in a porcine model of myocardial ischemia-reperfusion injury at 20 mg/kg
Formal name: butanedioic acid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester
Synonyms:
Molecular weight: 423.2
CAS: 3544-94-3
Purity: ≥99%
Formulation: A solid
Product Type|Biochemicals|Antibiotics|Amphenicols||Research Area|Cardiovascular System|Cardiovascular Diseases|Myocardial Infarction||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Bacterial Diseases